Does HBV Infection Increase Risk of Endometrial Carcinoma?

作者:Jiang, Xue-Feng*; Tang, Qiong-Lan; Zou, Yuan; Xu, Ling; Zeng, Hua; Chi, Cong; Jiang, Jing-Ru; Zhang, Bin-Zhong
来源:Asian Pacific Journal of Cancer Prevention, 2014, 15(2): 713-716.
DOI:10.7314/APJCP.2014.15.2.713

摘要

Objective: Connections between chronic inflammation and tumor development and progression are now generally accepted. Recent evidence indicates that hepatitis B is associated with several types of cancer, but whether endometrial carcinoma (EC) is included has not been reported. Methods: We analyzed HBV serum marker status in 398 patients with endometrial cancer, comparing them to 788 control women undergoing health examination. Results: The total prevalence of HBsAg tested positive in cancer group was significantly higher than the control group (12.8% vs 6.0%, P=0.001), while positive HBsAb was significantly lower (41.2% vs 68.5%, P=0.001). Hepatitis B carriers in endometrial cancer group were also more frequent than in the control group (9.3% vs 5.5%, P=0.013). Interestingly, in the endometrial cancer group, 147 cases were HBV serum marker negative, which was also higher than in the control group (36.9% vs 15.6%, P=0.001). Conclusion: There may be a correlation between HBV infection and endometrial carcinoma.